Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04682067 · ClinicalTrials.gov registry record · NA
Diabetes Smoking Cessation Incentives Study
A NA study, sponsored by University of Oklahoma.
- Completed
- Registry status
- NA
- Development phase
- 29
- Enrollment target
NCT04682067: Completed NA study, sponsored by University of Oklahoma.
NCT04682067 is a NA study that has completed, run by University of Oklahoma. The registered enrollment target is 29 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04682067, a NA study, has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the feasibility of contingency management on improving smoking cessation among individuals with type 2 diabetes.
Primary Outcome
Feasibility outcome: completion of 6 study visits
Interventions
- BEHAVIORAL Contingency Management
- BEHAVIORAL Usual Care smoking cessation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2021-01-08 |
| Est. Completion | 2022-04-07 |
| Phase | NA |
What the finished NCT04682067 record still lists
NCT04682067 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Contingency Management is the first listed.
NCT04682067 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04682067 about?
NCT04682067 is a clinical study titled "Diabetes Smoking Cessation Incentives Study". The purpose of this study is to evaluate the feasibility of contingency management on improving smoking cessation among individuals with type 2 diabetes.
What is the current status of trial NCT04682067?
This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2021-01-08. Estimated completion is 2022-04-07.
What interventions are being tested in trial NCT04682067?
The interventions under investigation include: Contingency Management (BEHAVIORAL), Usual Care smoking cessation (BEHAVIORAL).
Who is sponsoring clinical trial NCT04682067?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04682067's enrollment target sits among peer trials
29 1702nd of 2000 higher than 297 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI